BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27450485)

  • 1. Casticin inhibits lipopolysaccharide-induced acute lung injury in mice.
    Wang C; Zeng L; Zhang T; Liu J; Wang W
    Eur J Pharmacol; 2016 Oct; 789():172-178. PubMed ID: 27450485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genipin alleviates LPS-induced acute lung injury by inhibiting NF-κB and NLRP3 signaling pathways.
    Zhang A; Wang S; Zhang J; Wu H
    Int Immunopharmacol; 2016 Sep; 38():115-9. PubMed ID: 27262946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
    Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
    Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
    Yang S; Yu Z; Yuan T; Wang L; Wang X; Yang H; Sun L; Wang Y; Du G
    Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saikosaponin a Ameliorates LPS-Induced Acute Lung Injury in Mice.
    Du ZA; Sun MN; Hu ZS
    Inflammation; 2018 Feb; 41(1):193-198. PubMed ID: 28986747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of NLRP3 and NF-κB signaling pathways by α-Cyperone via activating SIRT1 contributes to attenuation of LPS-induced acute lung injury in mice.
    Liu X; Jin X; Yu D; Liu G
    Int Immunopharmacol; 2019 Nov; 76():105886. PubMed ID: 31520990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total flavonoids of Mosla scabra leaves attenuates lipopolysaccharide-induced acute lung injury via down-regulation of inflammatory signaling in mice.
    Chen J; Wang JB; Yu CH; Chen LQ; Xu P; Yu WY
    J Ethnopharmacol; 2013 Jul; 148(3):835-41. PubMed ID: 23747643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fraxin ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting the NF-κB and NLRP3 signalling pathways.
    Li W; Li W; Zang L; Liu F; Yao Q; Zhao J; Zhi W; Niu X
    Int Immunopharmacol; 2019 Feb; 67():1-12. PubMed ID: 30530164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of silibinin on LPS-induced acute lung injury by inhibiting NLRP3 and NF-κB signaling pathways.
    Tian L; Li W; Wang T
    Microb Pathog; 2017 Jul; 108():104-108. PubMed ID: 28483599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acanthoic acid ameliorates lipopolysaccharide-induced acute lung injury.
    Qiushi W; Guanghua L; Guangquan X
    Eur J Pharmacol; 2015 Mar; 750():32-8. PubMed ID: 25620130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compound edaravone alleviates lipopolysaccharide (LPS)-induced acute lung injury in mice.
    Zhang Z; Luo Z; Bi A; Yang W; An W; Dong X; Chen R; Yang S; Tang H; Han X; Luo L
    Eur J Pharmacol; 2017 Sep; 811():1-11. PubMed ID: 28552343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
    Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
    J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats.
    Wu Y; Huang D; Wang X; Pei C; Xiao W; Wang F; Wang Z
    Int Immunopharmacol; 2021 Jul; 96():107621. PubMed ID: 33872850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Garlic oil supplementation blocks inflammatory pyroptosis-related acute lung injury by suppressing the NF-κB/NLRP3 signaling pathway via H
    Dilxat T; Shi Q; Chen X; Liu X
    Aging (Albany NY); 2024 Apr; 16(7):6521-6536. PubMed ID: 38613798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aloin suppresses lipopolysaccharide-induced acute lung injury by inhibiting NLRP3/NF-κB via activation of SIRT1 in mice.
    Lei J; Shen Y; Xv G; Di Z; Li Y; Li G
    Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):306-313. PubMed ID: 32419528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
    Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of pogostone against LPS-induced acute lung injury in mice via regulation of Keap1-Nrf2/NF-κB signaling pathways.
    Sun CY; Xu LQ; Zhang ZB; Chen CH; Huang YZ; Su ZQ; Guo HZ; Chen XY; Zhang X; Liu YH; Chen JN; Lai XP; Li YC; Su ZR
    Int Immunopharmacol; 2016 Mar; 32():55-61. PubMed ID: 26800098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway.
    Niu X; Zang L; Li W; Xiao X; Yu J; Yao Q; Zhao J; Ye Z; Hu Z; Li W
    Int Immunopharmacol; 2020 Apr; 81():106024. PubMed ID: 31784404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg3 ameliorates lipopolysaccharide-induced acute lung injury in mice through inactivating the nuclear factor-κB (NF-κB) signaling pathway.
    Cheng Z; Li L
    Int Immunopharmacol; 2016 May; 34():53-59. PubMed ID: 26921732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.